Shaping the future of animal health
Virbac group

Products news

United States: two promising products

Monday, October 15, 2012 

Corporate news

United States: two promising products

Rilexine and Suprelorin F: two products launched in the American market mid 2012 thanks to the hard work of the Virbac US R&D teams to adapt the registration dossiers. A look at the challenges with Craig Parks, R&D vice-president.

Read more

Canine osteoarthritis: Virbac expands its product range in France

Friday, June 01, 2012 

Corporate news

Canine osteoarthritis: Virbac expands its product range in France

Since June 2012, Virbac France has offered a long-term treatment that aims to reduce inflammation and pain for dogs with acute and chronic musculoskeletal disorders. This medicine adds to Virbac's canine osteoarthritis range which now provides comprehensive care for canine osteoarthritis.

Read more

Pharmapack congress: a Virbac packaging rewarded

Friday, April 01, 2011 

Corporate news

01/02/2010. Paris - France. Pharmapack award "Home risks prevention - veterinary category" has been awarded to Milteforan, the first veterinary medicinal product intended to treat the leishmaniasis and that can be administered by oral route. 

Read more

Companion animals: Virbac is releasing a new external parasiticide onto the European market

Monday, May 25, 2009 

Corporate news

The fruit of several years of development, Effipro® Spot On and Effipro® Spray are two Fipronil-based medicines which treat flea and tick infestations in dogs and cats.

Read more

Share on Facebook Share on Google Print current page Display News RSS